« Previous
Next »
Titles
- Oncology pharmaceuticals: reproductive toxicity testing and labeling recommendations1
- Oncology therapeutic radiopharmaceuticals: nonclinical studies and labeling recommendations1
- One percent of drugs with Medicaid reimbursement were not FDA-approved1
- Opioid use decreased in Medicare Part D, while medication-assisted treatment increased1
- Opioid use disorder: developing depot buprenorphine products for treatment1
- Opioid use in Medicare Part D in Missouri1
- Organizational challenges to improving quality of care in Indian Health Service hospitals1
- Osteoporosis: nonclinical evaluation of drugs intended for treatment1